Power Probe Group, Inc. v. Innova Electronics Corporation

District Court, D. Nevada·Decided October 25, 2023·No. 2:21-cv-00332·Unknown

Opinion

1 UNITED STATES DISTRICT COURT

2 DISTRICT OF NEVADA 3

4 POWER PROBE GROUP, INC., ) ) Case No.: 2:21-cv-00332-GMN-EJY 5 Plaintiff, ) 6 vs. ) ORDER GRANTING PRELIMINARY ) INJUNCTION 7 INNOVA ELECTRONICS, CORP. ) ) 8 Defendant. ) ) 9 10 Pending before the Court is Plaintiff Power Probe Group Inc.’s Motion for Preliminary 11 Injunction, (ECF No. 36). Defendant Innova Electronics Corporation filed a Response, (ECF 12 No. 54), to which Plaintiff filed a Reply, (ECF No. 57). 13 For the reasons discussed below, the Court GRANTS Plaintiff’s Motion for Preliminary 14 Injunction. 15 I. BACKGROUND 16 This case arises from Defendant’s alleged infringement of United States Patent No. 17 7,184,899 (“the ‘899 Patent”). (Compl. ¶ 14). The ‘899 Patent teaches an “Energizable 18 Electrical Test Device For Measuring Current and Resistance of an Electrical Circuit.” (See 19 ‘899 Patent, Ex. 1 to Compl., ECF No. 1-2). Defendant offers a competing product for sale, the 20 Innova PowerCheck #5420 (the “Accused Product”). Plaintiff alleges that the Accused Product 21 practices at least each limitation of Claim One of the ‘899 Patent. (See generally Mot. Prelim. 22 Inj. (“Mot. PI”), ECF No. 36); (Product Page – Innova PowerCheck, Ex. 5 to Decl. Christian JJ 23 Paredis, Ph.D (“Paredis Decl.”), Ex. A to Mot. PI, ECF No. 37-5). 24 Following briefing, the Court conducted a two-day hearing on Plaintiff’s Motion for 25 Preliminary Injunction. (See Mins. Proceedings, ECF Nos. 93, 95). Based on the parties’ 1 briefing and testimony, this Court denied the motion for failing to raise serious questions on the 2 merits that the Accused Product performs “measurement of a plurality of parameters.” (Order 3 Denying P.I., ECF No. 101). To prove a likelihood of success on the merits, Plaintiff must 4 prove that the Accused Product measures continuity in addition to voltage. (Id. 9:18–23). 5 Because this Court found that the Accused Product merely detects continuity, the Court 6 determined that the Accused Product did not measure continuity. (Id. 9:18–10:2). 7 On appeal, the Federal Circuit concluded that that the District Court “erred in construing 8 ‘continuity’ as a parameter that is not measurable,” and vacated and remanded for further 9 proceedings regarding whether Plaintiff met the requirements for a preliminary injunction. 10 (Fed. Cir. Op. at 5, ECF No. 141). Following instruction from the Court on remand, the parties 11 filed supplemental briefing. (See ECF Nos. 153, 154). 12 II. LEGAL STANDARD 13 “A plaintiff seeking a preliminary injunction must establish that he is likely to succeed 14 on the merits, that he is likely to suffer irreparable harm in the absence of preliminary relief, 15 that the balance of equities tips in his favor, and that an injunction is in the public interest.” 16 Winter v. NRDC, Inc., 555 U.S. 7, 20, (2008). Injunctive relief is “an extraordinary remedy that 17 may only be awarded upon a clear showing that the plaintiff is entitled to such relief.” Id. at 22. 18 “[C]ourts must balance the competing claims of injury and must consider the effect on each 19 party of the granting or withholding of the requested relief.” Id. at 24 (internal quotation marks 20 omitted). The Ninth Circuit has held that “serious questions going to the merits and a hardship 21 balance that tips sharply toward the plaintiff can support issuance of an injunction, assuming 22 the other two elements of the Winter test are also met.” Alliance for the Wild Rockies v. 23 Cottrell, 632 F.3d 1127, 1132 (9th Cir. 2011) (internal quotation marks omitted). 24 ///

25 // 1 III. DISCUSSION 2 “Courts have the power to grant injunctions to prevent the violation of patent rights.” 3 Pfizer, Inc. v. Teva Pharms., USA, Inc., 429 F.3d 1364, 1372 (Fed. Cir. 2005) (citing 35 U.S.C. 4 § 283 (2000)). “In considering whether to grant a preliminary injunction, a court must consider 5 whether the patent owner has shown: (1) a reasonable likelihood of success on the merits; (2) 6 the prospect of irreparable harm to the patent owner; (3) the balance of hardships tips in its 7 favor; and (4) granting the injunction would not adversely affect the public interest.” Id. Before 8 the Court can determine the patent holder’s likelihood of success on the merits, the Court must 9 first make preliminary decisions on relevant disputed terms. Then, the Court will determine 10 whether Plaintiff has sufficiently shown the four preliminary injunction factors. 11 A. Preliminary Claim Construction 12 “It is a bedrock principle of patent law that the claims of a patent define the invention to 13 which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 14 1312 (Fed. Cir. 2005) (en banc) (citations and internal quotation marks omitted). The 15 interpretation of the scope and meaning of disputed terms in patent claims is a question of law 16 and exclusively within the province of a court to decide. Markman v. Westview Instruments, 17 Inc., 517 U.S. 370, 372 (1996). When construing disputed claim terms, the Court must give 18 each disputed term “the meaning that the term would have to a person of ordinary skill in the 19 art at the time of the invention,” unless the patentee clearly intended a different definition. 20 Phillips v. AWH Corp., 415 F.3d 1303, 1312–13 (Fed. Cir. 2005). Furthermore, “the person of 21 ordinary skill in the art is deemed to read the claim term not only in the context of the particular 22 claim in which the disputed term appears but in the context of the entire patent, including the 23 specification.” Id. at 1313. 24 In certain cases, “the ordinary meaning of claim language as understood by a person of

25 skill in the art may be readily apparent even to lay judges, and claim construction in such cases 1 involves little more than the application of the widely accepted meaning of commonly 2 understood words.” Id. at 1314. In other instances, the claim term may have a particular 3 meaning in the field of art that is not immediately clear. Id. In such cases, the Federal Circuit 4 has instructed that a court’s analysis should focus on the intrinsic evidence, including “the 5 words of the claims themselves, the remainder of the specification, the prosecution history, and 6 extrinsic evidence concerning relevant scientific principles, the meaning of technical terms, and 7 the state of the art.” Id. “[T]he claims themselves provide substantial guidance as to the 8 meaning of particular claim terms.” Id. “Other claims of the patent in question, both asserted 9 and unasserted, can also be valuable sources of enlightenment as to the meaning of a claim 10 term.” Id. Specifically, differences between the claims often provide useful guidance in 11 understanding the meaning of the claim terms. Id. “For example, the presence of a dependent 12 claim that adds a particular limitation gives rise to a presumption that the limitation in question 13 is not present in the independent claim.” Id. at 1314–15. 14 The claims, however, are not read in isolation; rather, the Court must read claims in light 15 of the entire specification of which the claims are a part. Id. In fact, the specification is “the 16 single best guide to the meaning of a disputed term.” Vitronics Corp. v. Conceptronic, Inc., 90 17 F.3d 1576, 1582 (Fed. Cir. 1996). Courts also look to the prosecution history as part of the 18 intrinsic record to determine how the Patent Office and the inventor understood the patent. 19 Phillips, 415 F.3d at 1317.

Free access — add to your briefcase to read the full text and ask questions with AI

Power Probe Group, Inc. v. Innova Electronics Corporation, (D. Nev. 2023).

Power Probe Group, Inc. v. Innova Electronics Corporation (Power Probe Group, Inc. v. Innova Electronics Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Junior Money Bags, Ltd. v. Segal
970 F.2d 1 (Fifth Circuit, 1992)
United Carbon Co. v. Binney & Smith Co.
317 U.S. 228 (Supreme Court, 1942)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
ASTRAZENECA LP v. Apotex, Inc.
633 F.3d 1042 (Federal Circuit, 2010)
Titan Tire Corp. v. Case New Holland, Inc.
566 F.3d 1372 (Federal Circuit, 2009)
Sanofi-Synthelabo v. Apotex, Inc.
470 F.3d 1368 (Federal Circuit, 2006)
Pfizer, Inc. v. Teva Pharmaceuticals Usa, Inc.
429 F.3d 1364 (Federal Circuit, 2005)
Salazar v. Procter & Gamble Company
414 F.3d 1342 (Federal Circuit, 2005)
Hybritech Incorporated v. Monoclonal Antibodies, Inc.
802 F.2d 1367 (Federal Circuit, 1986)
Hybritech Incorporated v. Abbott Laboratories
849 F.2d 1446 (Federal Circuit, 1988)
Robert Bosch LLC v. Pylon Manufacturing Corp.
659 F.3d 1142 (Federal Circuit, 2011)
Celsis in Vitro, Inc. v. CellzDirect, Inc.
664 F.3d 922 (Federal Circuit, 2012)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
F. Brantley Scott and John H. Burton v. Roy P. Finney
34 F.3d 1058 (Federal Circuit, 1994)